The effect of L-carnitine on erectile dysfunctio
Phase 3
- Conditions
- Erectile dysfunction.Male erectile dysfunction
- Registration Number
- IRCT20200714048106N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 40
Inclusion Criteria
Erectile dysfunction
Diagnose type 2 diabetes for at least three months
No history of taking sildenafil citrate or L-carnitine during the previous three months
Exclusion Criteria
Patients with spinal cord injury
Patients treated with sildenafil citrate or L-carnitine.
Severe kidney failure
Known liver disease
Erectile dysfunction (ED) with known and treated origin of psychological disorder
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Erectile function. Timepoint: After 4 weeks. Method of measurement: International index of erectile function 5 (IIEF5).
- Secondary Outcome Measures
Name Time Method